Stryker to acquire Vocera Communications for nearly $3B in cash

  • Stryker (NYSE:SYK) announced an agreement to acquire the health-tech firm Vocera Communications (NYSE:VCRA) for $79.25 per share indicating a total equity value of ~$2.97B or $3.09B in enterprise value (including convertible notes). Vocera (VCRA) shares have added ~26.5% while Stryker (SYK) has lost ~0.8% in the pre-market.
  • The boards of directors of both companies have cleared the deal which is expected to close in Q1 2022. It will have a neutral impact on net earnings per diluted share in 2022, Stryker (SYK) said.
  • Per the terms, Stryker (SYK) will begin a tender offer for all outstanding shares of common stock of Vocera (VCRA) with $79.25 per share in cash.
  • Founded in 2020, San Jose, California-based Vocera (VCRA) provided clinical communication and workflow solutions for healthcare. Its share price gained ~44.4% over the past twelve months amid Bullish ratings among Wall Street analysts.

    For this year Stryker 's (located in Portage) revenue will be around 17.04 billion USD. This is according to the average of the analysts' estimates. This is quite more than 2021's revenue of 14.35 billion USD.

    Historical revenues and results Stryker plus estimates 2021

    beurskoers

    The analysts expect for 2021 a net profit of 3.42 billion USD. According to most of the analysts the company will have a profit per share for this book year of 9.11 USD. Based on this the price/earnings-ratio is 29.28.

    Per share the analysts expect a dividend of 2.52 USD per share. Thus the dividend yield equals 0.94 percent. The average dividend yield of the health care companies is a low 1.27 percent.

    Based on the current number of shares Stryker 's market capitalization equals 99.88 billion USD. 11

    On Friday the stock closed at 266.71 USD.

    Historical stock prices Stryker

    stock price stryker

    ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
    news@valuespectrum.com

    Copyright analist.nl B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.